The<unk>  <unk>  was established in 1955 as one of the first<unk>  groups launched to perform multi-center cancer clinical trials. A<unk>  group is a large network of researchers, physicians, and health care professionals at public and private institutions across the country who are members of the group. Funded primarily by the National Cancer Institute (NCI),<unk>  has evolved from a five member consortium of institutions on the East Coast to one of the largest clinical cancer research organizations in the U.S. with almost 6,000 physicians, nurses, pharmacists, statisticians, and clinical research associates (CRAs) from the U.S., Canada, and South Africa. Institutional members include universities, medical centers, Community Clinical<unk>  Programs (CCOPs), and<unk>  Group Outreach Programs (CGOPs). These institutions work toward the common goal of controlling, effectively treating, and ultimately curing cancer. Research results are provided to the world-wide medical community through scientific publications and professional meetings.
Currently,<unk>  has more than 90 active clinical trials in all types of adult malignancies. Annual accrual is 6,000 patients, with more than 20,000 patients in follow-up.<unk> 's coordinating center is based in Boston, Massachusetts while its Group Chair's office is located in Philadelphia, Pennsylvania.
Eastern Cooperative Oncology Group
Functional group
Ann Arbor staging
Bloom-Richardson grade
Lymphadenopathy classification
Vulvar cancer classification
Pregnancy category
Cluster of differentiation